IND126 / VeGen Labs - LARVOL DELTA

VeGen Labs secures BIRAC funding of Rs 3.76 Cr to advance KRAS inhibitor (BioSpectrum India) - "Hyderabad-based biotechnology startup VeGen Labs LLP has been awarded Rs 3.765 crore Royalty-based financial support from Biotechnology Industry Research Assistance Council (BIRAC), a Government of India enterprise set-up by Department of Biotechnology. This funding will support Investigational New Drug (IND)-enabling toxicology studies for IND126, a novel KRAS inhibitor, marking a significant step toward clinical development for Non-Small Cell Lung Cancer (NSCLC) patients in India....The BIRAC funding will enable comprehensive toxicology assessments, a critical step in preparing for IND submission with regulatory agencies. Upon successful completion, VeGen Labs will be positioned to initiate first-in-human clinical trials, further strengthening India’s role in cutting-edge drug discovery and precision oncology."

Financing • Non Small Cell Lung Cancer